An Abbreviated New Drug Application is an application for a U.S. generic drug approval for an existing licensed medication or approved drug. From Wikipedia
Final USFDA clearance for two vial strengths boosts Alembic’s generics portfolio to 224 approvals, underscoring its expansion in injectable oncology drugs
